evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/geneAliases/5,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract
1230,GENE_BACKGROUND,,"EGFR encodes the Epidermal Growth Factor Receptor. Binding of EGFR by its ligands, which includes Epidermal Growth Factor (EGF) and Transforming Growth Factor-alpha (TGF-alpha), activates downstream signaling pathways including the canonical oncogenic MAPK and PI3K/AKT/mTOR signaling cascades, ultimately resulting in changes in cellular proliferation, migration, and differentiation (PMID: 18045542). While EGFR usually is expressed at low levels in normal adult tissues, hyperactivation of this receptor by mutations and/or amplification of the EGFR gene is found in many cancer types such as lung, brain, colorectal and head and neck cancer (PMID: 10880430). In brain and colorectal cancers, copy number amplification of the EGFR gene results in receptor overexpression (PMID: 11426640). However, in lung cancer, the most prevalent EGFR alterations are mutations in the kinase domain resulting in a constitutively activated form of the receptor (PMID: 15329413). Activating mutations in EGFR are rarely found in pancreatic adenocarcinomas and colorectal cancer (PMID: 24827134).",,2017-07-29,,1956,EGFR,epidermal growth factor receptor,True,ENST00000275493,NM_005228.3,PIG61,ERBB1,mENA,ERBB,HER1,NISBD2,False,15329413,"EGF receptor gene mutations are common in lung cancers from ""never smokers"" and are associated with sensitivity of tumors to gefitinib and erlotinib.",Proceedings of the National Academy of Sciences of the United States of America,2018-09-07T20:04:00,101,36,13306-11,Pao W et al,,,0001-09-07,,24827134,"Phase II, randomized, biomarker identification trial (MARK) for erlotinib in patients with advanced pancreatic carcinoma.",Annals of oncology : official journal of the European Society for Medical Oncology,2018-07-01T20:14:00,25,7,1384-90,Propper D et al,doi: 10.1093/annonc/mdu176,,0001-07-01,,18045542,SnapShot: EGFR signaling pathway.,Cell,2017-11-30T20:07:00,131,5,1018,Yarden Y et al,,,0001-11-30,,10880430,The ErbB signaling network: receptor heterodimerization in development and cancer.,The EMBO journal,2018-07-03T20:00:00,19,13,3159-67,Olayioye MA et al,,,0001-07-03,,11426640,The EGF receptor family as targets for cancer therapy.,Oncogene,2017-12-27T20:00:00,19,56,6550-65,Mendelsohn J et al,,,0001-12-27,
1229,GENE_SUMMARY,,"EGFR, a receptor tyrosine kinase, is altered by amplification, mutation and/or overexpression in various cancers, most frequently in lung and brain cancers.",,2017-04-28,,1956,EGFR,epidermal growth factor receptor,True,ENST00000275493,NM_005228.3,PIG61,ERBB1,mENA,ERBB,HER1,NISBD2,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
